CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
Jaguar Uranium Reports Preliminary Surface Sampling Results from Huemul Uranium-Copper-Vanadium Project
Goldgroup Mining and Gold Resource Corporation Announce Closing of Business Combination and Goldgroup's Anticipated Listing on the NYSE American
